Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
[16] [2] Conditions such as hypothyroidism, polycystic ovary syndrome (PCOS), or previous metabolic surgery may alter treatment response
Retatrutide (formerly LY3437943) is a once-weekly injectable drug developed by Eli Lilly
Minimal Side Effects: The peptide is generally well-tolerated, with most users reporting only mild side effects like headaches or increased energy
But the drug's weight-loss benefits weren't enough for her to stick with it, and she stopped taking it after seven months
US$ 27.12
US$ 23.69
US$ 28.41
US$ 23.08
